Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents

scientific article published on 01 March 1998

Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S1359-6101(97)00037-3
P698PubMed publication ID9720757

P50authorBarbara EnsoliQ21255143
Michael StürzlQ41520499
P2093author name stringB Ensoli
P2860cites workOncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cellsQ24305320
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequenceQ24561727
A novel endothelial-specific membrane protein is a marker of cell-cell contactsQ24642987
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)Q24650427
The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigenQ24672438
AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodiesQ24678972
The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT proteinQ24680024
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcomaQ28242984
HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic regionQ28252310
Expression of fibroblast growth factors and their receptors in acquired immunodeficiency syndrome-associated Kaposi sarcoma tissue and derived cellsQ28262598
Disseminated Kaposi's sarcoma syndrome in young homosexual menQ28281021
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin MQ28284457
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomasQ28299069
Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cellsQ32163310
Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patientQ33489423
AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6Q33602539
Expression of int-2 oncogene in Kaposi's sarcoma lesionsQ33894163
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic resultsQ34055989
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.Q34155667
Platelet-derived growth factor BB induces functional vascular anastomoses in vivoQ34165679
Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.Q34209585
Angiogenic properties of human immunodeficiency virus type 1 Tat proteinQ34267637
Treatment of HIV-associated Kaposi's sarcoma with paclitaxelQ34299276
Inactivation of Bcl-2 by phosphorylationQ34340301
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcomaQ34383343
The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmissionQ34388952
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.Q34408877
The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndromeQ34693731
Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsiesQ34731756
Transcription of human herpesvirus-like agent (HHV-8) in Kaposi's sarcomaQ34733565
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcomaQ34735185
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigenQ34735858
Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclinsQ43566357
Endemic African Kaposi's sarcoma is not associated with immunodeficiencyQ43597052
Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patientsQ43823829
Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma.Q43932714
The appearance of Kaposi sarcoma during corticosteroid therapyQ43988225
Infectious human herpesvirus 8 in a healthy North American blood donorQ44132374
Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2.Q44213622
Microsatellite instability in primary neoplasms from HIV+ patientsQ44222153
Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma.Q44677526
Birthplace and classic Kaposi's sarcoma in Italy. Associazione Italiana Registri TumoriQ44737224
The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growthQ45292376
Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat ProteinQ45734648
Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).Q45838520
Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.Q45878585
Macrophages and vascular adhesion molecules in oral Kaposi's sarcomaQ46482018
An immunohistochemical study of p53 protein expression in classical Kaposi's sarcoma.Q52200372
Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.Q52833089
Immunological Studies in Kaposi's Sarcoma in UgandaQ54060229
Interferon-gamma marks activated T lymphocytes in AIDS patients.Q54320989
Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS.Q54332249
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.Q54565305
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.Q55242415
Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologueQ56999807
Kaposi's sarcoma and KSHVQ58283364
Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma.Q35426283
Kaposi's sarcoma: a review of gene expression and ultrastructure of KS spindle cells in vivoQ35565392
Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcomaQ35732449
Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesisQ35752847
Human herpesvirus 8 encodes a homolog of interleukin-6.Q35876140
Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcomaQ35967211
Kaposi's sarcoma in mainland Tanzania: a report of 117 casesQ36037978
Kaposi's Sarcoma in Uganda: Geographic and Ethnic DistributionQ36039507
Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cellsQ36366617
The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients.Q36366989
Cytokines and endothelial cell biologyQ36565690
Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenanceQ37133813
Differential activation of the extracellular signal-regulated kinase, Jun kinase and Janus kinase-Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi's sarcoma cellsQ38359607
High incidence of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in tumor lesions and peripheral blood mononuclear cells from patients with Kaposi's sarcoma in UgandaQ38887862
Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individualsQ38888150
Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in AfricaQ39122647
A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcomaQ39435212
The human hematopoietic colony-stimulating factorsQ39656937
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cellsQ39877852
Large clonal expansions of CD8+ T cells in acute infectious mononucleosisQ40665903
Clinical aspects of AIDS-related Kaposi's sarcomaQ40770536
Scatter factor and angiogenesisQ40951683
Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcomaQ40972068
Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcomaQ41100256
The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells.Q41247263
Isolation and Characterization of an Immortal Neoplastic Cell Line (KS Y-1) From AIDS-Associated Kaposi's SarcomaQ41327013
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.Q41335848
Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcomaQ41435232
Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animalsQ41472104
Cytokine regulation of endothelial cell function: from molecular level to the bedsideQ41472342
Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulationQ41534380
Kaposi's sarcoma in organ transplant recipients: report of 20 casesQ41593468
AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factorQ41633966
Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosisQ41671465
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patientsQ41734588
Cytochemical and molecular properties of simian virus 40 transformed Kaposi's sarcoma-derived cells: evidence for the secretion of a member of the fibroblast growth factor familyQ41760163
Inhibition of endothelial cell growth by macrophage-like U-937 cell-derived oncostatin M, leukemia inhibitory factor, and transforming growth factor beta1.Q42522979
Cyclin encoded by KS herpesvirusQ42633290
Monoclonal Origin of Multicentric Kaposi's Sarcoma LesionsQ58366797
Over-expression of hepatocyte growth factor in human Kaposi's sarcomaQ58907097
The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic miceQ59060595
Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferateQ59071792
Kaposi's Sarcoma–Associated Herpesvirus DNA Sequences in Prostate Tissue and Human SemenQ59647839
Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcomaQ61641145
Immune response of elderly individuals to a live attenuated varicella vaccineQ67492597
Cellular and molecular features of HIV-associated Kaposi's sarcomaQ67548418
Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individualsQ67986148
Kaposi's sarcoma: further immunohistologic evidence of a vascular endothelial originQ68060823
Cultured Kaposi's sarcoma-derived cells express functional PDGF A-type and B-type receptorsQ68447546
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndromeQ68498654
Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferonQ68931996
Endothelial cell markers in vascular neoplasms: an immunohistochemical study comparing factor VIII-related antigen, blood group specific antigens, 6-keto-PGF1 alpha, and Ulex europaeus 1 lectinQ68969090
Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcomasQ69368465
Angioproliferative changes in clinically noninvolved, perilesional skin in AIDS-associated Kaposi's sarcomaQ69468698
Possible role of natural cytotoxic activity in the pathogenesis of AIDSQ69735075
Epidermal tumour necrosis factor alpha and interleukin 6-like activities in AIDS-related Kaposi's sarcoma. An immunohistological studyQ69740016
Myopathy in McArdle's syndromeQ69836175
Human endothelial cell cultures: phenotypic modulation by leukocyte interleukinsQ69864531
Kaposi's sarcoma: a reversible hyperplasiaQ69890531
Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytesQ70474464
Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cellsQ71563744
Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cellsQ71651411
Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patientsQ71735402
Herpesvirus-like DNA Sequences in Non-AIDS Kaposi's SarcomaQ71829854
Herpes-Like DNA Sequences, AIDS-Related Tumors, and Castleman's DiseaseQ71980431
Occurrence of human papillomavirus and p53 gene mutations in Kaposi's sarcomaQ72058383
TGFβ and FGF-like growth factors involved in the pathogenesis of AIDS-associated Kaposi's sarcomaQ72072566
Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1Q72100625
Kaposi's sarcoma and new herpesvirusQ72172762
Immunohistochemical localization of transforming growth factor-beta 1 in Kaposi's sarcomaQ72238371
Kaposi's sarcoma with benign course in a homosexualQ72520368
Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcomaQ72633360
Distribution of immunocompetent cells in oral Kaposi's sarcoma (AIDS)Q72666198
A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high-risk individualsQ72712217
Increased cytokine production in mononuclear cells of healthy elderly peopleQ72921117
Activation of HHV-8 by HIV-1 tatQ73164633
Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopyQ73236623
Human herpesvirus type 8 DNA sequences in biological samples of HIV-positive and negative individuals in SicilyQ73236637
Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patientsQ73427581
Clonality in Kaposi's sarcomaQ73609603
Cell adhesion and angiogenesisQ80120180
Spontaneous regression of Kaposi's sarcoma in patients with AIDSQ93650974
P433issue1
P921main subjectKaposi's sarcomaQ725345
P304page(s)63-83
P577publication date1998-03-01
P1433published inCytokine and Growth Factor ReviewsQ15763303
P1476titleKaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents
P478volume9

Reverse relations

cites work (P2860)
Q38884285A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area.
Q59621919AIDS-associated malignancies
Q41494543Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype
Q33948194Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor
Q30441657Activation of p90 ribosomal S6 kinase by ORF45 of Kaposi's sarcoma-associated herpesvirus and its role in viral lytic replication
Q34992555Activation of p90 ribosomal S6 kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus is critical for optimal production of infectious viruses
Q33647345Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells
Q36336086An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypes
Q64102452Arachidonic Acid Derived Lipid Mediators Influence Kaposi's Sarcoma-Associated Herpesvirus Infection and Pathogenesis
Q36782271CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells.
Q90266553Cancer prevention and control: Kaposi's sarcoma
Q64263465Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication
Q39597623Characterization of human herpesvirus 8 ORF59 protein (PF-8) and mapping of the processivity and viral DNA polymerase-interacting domains
Q33984196Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome
Q59353572Chemokine Subversion by Human Herpesviruses
Q40067378Chemokines encoded by herpesviruses
Q39748116De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells
Q28359690Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells
Q45723844Epstein‐Barr Virus and Human Herpesvirus 8 Coinfection and Concomitant Extranodal Nasal‐Type NK/T Cell Lymphoma and Castleman Disease: Case Report
Q33824614Evasion and exploitation of chemokines by viruses
Q47601651Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition
Q40871620Expression of functional tyrosine kinases on immortalized Kaposi's sarcoma cells
Q35315503Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation
Q61641137HHV-8 and multistep tumorigenesis
Q40747284HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma
Q47217828HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy
Q34963626Higher levels of neutralizing antibodies against KSHV in KS patients compared to asymptomatic individuals from Zambia
Q26767036Historical review of the causes of cancer
Q40860049Human endothelial cells expressing polyoma middle T induce tumors
Q39733480Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequence
Q42202708Human herpesvirus 8 viral interleukin-6 signaling through gp130 promotes virus replication in primary effusion lymphoma and endothelial cells
Q34295801Human herpesvirus-8 and Kaposi's sarcoma: relationship with the multistep concept of tumorigenesis.
Q36238078Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Q47367466Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.
Q37209090Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation
Q40364647Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.
Q42710003Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells
Q35752316Inhibiting the Recruitment of PLCγ1 to Kaposi's Sarcoma Herpesvirus K15 Protein Reduces the Invasiveness and Angiogenesis of Infected Endothelial Cells
Q40438343Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival.
Q33491306Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells
Q34615002Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system
Q37033410Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6
Q33761091KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine
Q98299755KSHV enhances mesenchymal stem cell homing and promotes KS-like pathogenesis
Q26742030KSHV-Mediated Angiogenesis in Tumor Progression
Q94012444Kaposi sarcoma
Q41919772Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes
Q37632632Kaposi's Sarcoma-Associated Herpesvirus Subversion of the Anti-Inflammatory Response in Human Skin Cells Reveals Correlates of Latency and Disease Pathogenesis
Q44277985Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.
Q39683376Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production
Q33960391Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma.
Q28388436Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1
Q24629364Kaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cells
Q40105629Kaposi's sarcoma-associated herpesvirus infection promotes differentiation and polarization of monocytes into tumor-associated macrophages
Q39792755Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes.
Q35641026Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis
Q36363240Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression
Q35785255Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1
Q36506932Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection.
Q39305101Kaposi's sarcoma-associated herpesvirus virions inhibit interferon responses induced by envelope glycoprotein gpK8.1.
Q37478443Lung Malignancies in HIV Infection
Q40218296Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus
Q35124404Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis
Q33560572Molecular biology of KSHV in relation to AIDS-associated oncogenesis
Q34013830Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication
Q40031635Opposing roles of RNA receptors TLR3 and RIG-I in the inflammatory response to double-stranded RNA in a Kaposi's sarcoma cell line
Q92278120PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment
Q35174136Pathogenesis of Kaposi's sarcoma
Q36546999Professional antigen presenting cells in human herpesvirus 8 infection
Q52561164RNA epitranscriptomics: Regulation of infection of RNA and DNA viruses by N6 -methyladenosine (m6 A).
Q34295807Reactivation and role of HHV-8 in Kaposi's sarcoma initiation
Q34291063Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression
Q55338587Role of Pattern Recognition Receptors in KSHV Infection.
Q28829309Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus
Q39776585Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein
Q47606690TLR4-Mediated Inflammation Promotes KSHV-Induced Cellular Transformation and Tumorigenesis by Activating the STAT3 Pathway
Q35066362The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis
Q57160789The RNA epitranscriptome of DNA viruses
Q37288834The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells
Q39860135The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.
Q35590378Treatment of Disseminated Classic Type of Kaposi's Sarcoma with Paclitaxel

Search more.